Women Still Face Lung Transplant Barriers Despite Policy Overhaul

Problem-solution framing emphasizing persistent inequality despite reform efforts. Uses expert authority (Dr. Ardehali) to validate concerns while acknowledging modest progress, creating narrative of incomplete progress requiring further action.

Not applicable - this concerns internal U.S. healthcare policy and medical equity within the transplant system, not international relations or geopolitical competition.

Women face reduced access to life-saving lung transplants, increasing healthcare costs through prolonged illness, reduced workforce participation, and potential increased mortality. Families bear higher out-of-pocket costs and lost income from caregiving. This creates disparate health outcomes and economic burden on female patients and households.

Continued regulatory refinement of organ allocation algorithms needed; potential CMS reimbursement adjustments; increased funding for transplant research addressing biological compatibility; possible legislative mandates for equity metrics in transplant centers; healthcare equity oversight expansion; potential liability exposure for transplant programs not meeting equity benchmarks.